Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,290
+200 (1.80%)
At close: Feb 20, 2026

Samil Pharmaceutical Co.,Ltd Company Description

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea.

It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products.

The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments.

Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Samil Pharmaceutical Co.,Ltd
CountrySouth Korea
Founded1947
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees583
CEOSeung Bum Huh

Contact Details

Address:
155 Hyoryeong-Ro
Seoul
South Korea
Phone82 2 520 0300
Websitesamil-pharm.com

Stock Details

Ticker Symbol000520
ExchangeKorea Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7000520007
SIC Code2834

Key Executives

NamePosition
Seung Bum HuhChief Executive Officer and Chairman
Yu Seok ShinPresident and Director
Joon Beom HuhExecutive Director
Tae Keun KwonVice President and Director